TriSalus Life Valuation
| TLSIW Stock | 1.33 0.08 6.40% |
Today, the company appears to be overvalued. TriSalus Life Sciences has a current Real Value of USD1.11 per share. The regular price of the company is USD1.33. Our model measures the value of TriSalus Life Sciences from inspecting the company fundamentals such as Return On Asset of -0.92, number of shares shorted of 687, and Gross Profit of 23.42 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that TriSalus Life's price fluctuation is abnormally volatile at this time. Calculation of the real value of TriSalus Life Sciences is based on 3 months time horizon. Increasing TriSalus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the TriSalus stock is determined by what a typical buyer is willing to pay for full or partial control of TriSalus Life Sciences. Since TriSalus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TriSalus Stock. However, TriSalus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.33 | Real 1.11 | Hype 1.18 | Naive 1.41 |
The intrinsic value of TriSalus Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence TriSalus Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of TriSalus Life Sciences helps investors to forecast how TriSalus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TriSalus Life more accurately as focusing exclusively on TriSalus Life's fundamentals will not take into account other important factors: TriSalus Life Cash |
|
TriSalus Life Total Value Analysis
TriSalus Life Sciences is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of 51.66 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the TriSalus Life fundamentals before making investing decisions based on enterprise value of the companyTriSalus Life Investor Information
The company had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from TriSalus Life's historical financial statements, TriSalus Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.TriSalus Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TriSalus Life has an asset utilization ratio of 71.96 percent. This indicates that the Company is making USD0.72 for each dollar of assets. An increasing asset utilization means that TriSalus Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.TriSalus Life Profitability Analysis
The company reported the revenue of 18.51 M. Net Loss for the year was (59.04 M) with profit before overhead, payroll, taxes, and interest of 23.42 M.About TriSalus Life Valuation
Our relative valuation model uses a comparative analysis of TriSalus Life. We calculate exposure to TriSalus Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TriSalus Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 18.3 M | 12.2 M |
TriSalus Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as TriSalus Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 26.4 M |
Additional Tools for TriSalus Stock Analysis
When running TriSalus Life's price analysis, check to measure TriSalus Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TriSalus Life is operating at the current time. Most of TriSalus Life's value examination focuses on studying past and present price action to predict the probability of TriSalus Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TriSalus Life's price. Additionally, you may evaluate how the addition of TriSalus Life to your portfolios can decrease your overall portfolio volatility.